Picture of Klaria Pharma Holding AB (publ) logo

KLAR — Klaria Pharma Holding AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Klaria Signs Exclusive Development, License And Supply Agreements With Purdue Pharma

Jan 22 (Reuters) - Klaria Pharma Holding AB (publ)  KLAR.ST :
    * KLARIA SIGNS EXCLUSIVE DEVELOPMENT, LICENSE AND SUPPLY AGREEMENTS WITH PURDUE PHARMA
(CANADA)
FOR THE EMERGENCY TREATMENT OF ANAPHYLACTIC REACTIONS
    * IN ADDITION, KLARIA WILL RECEIVE MID-TO-UPPER SINGLE DIGIT ROYALTIES ON NET SALES

Source text for Eikon:  ID:nWkr7mMtkl 
Further company coverage:  KLAR.ST 

 (Gdynia Newsroom)
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Klaria Pharma Holding AB (publ)

See all news